{
    "organizations": [],
    "uuid": "2cf4b507b611b81670bd000b93c0b8d96e3c66e1",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/04/02/the-associated-press-oncocyte-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "OncoCyte reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "ALAMEDA, Calif. (AP) _ OncoCyte Corp. (OCX) on Monday reported a loss of $4 million in its fourth quarter.\nOn a per-share basis, the Alameda, California-based company said it had a loss of 13 cents.\nFor the year, the company reported that its loss widened to $19.4 million, or 64 cents per share.\nIn the final minutes of trading on Monday, the company's shares hit $2.25. A year ago, they were trading at $5.95.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on OCX at https://www.zacks.com/ap/OCX",
    "published": "2018-04-03T01:05:00.000+03:00",
    "crawled": "2018-04-03T00:49:47.033+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "alameda",
        "ap",
        "oncocyte",
        "ocx",
        "monday",
        "reported",
        "loss",
        "million",
        "fourth",
        "quarter",
        "basis",
        "alameda",
        "company",
        "said",
        "loss",
        "cent",
        "year",
        "company",
        "reported",
        "loss",
        "widened",
        "million",
        "cent",
        "per",
        "share",
        "final",
        "minute",
        "trading",
        "monday",
        "company",
        "share",
        "hit",
        "year",
        "ago",
        "trading",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "ocx",
        "http"
    ]
}